Mode Dx’s business model recognizes the need to form strategic partnering and licensing arrangements to optimize revenue streams and shareholder value. Enquiries are welcomed from any company interested in discussing:
Licensing of near patient IP for application refocusing by Mode Dx.
Joint development projects for novel detection of biomarkers.
R&D collaboration; adding functionality to your product.
Out-licensing of product/technology opportunities that align with Mode Dx’s strategic fit.